Table 1 Baseline characteristics and demographic of the study population (data are presented as mean (SD) unless otherwise noted)
Variable | Description |
|---|---|
Age (yr) | 63.4 (7) |
Female (n, %) | 732 (35 %) |
Current smokers (n, %) | 767 (36 %) |
Post bronchodilator FEV1 (litres) | 1.35 ± (0.52) |
Post bronchodilator % predicted FEV1 | 48 ± (16) |
FEV1/FVC (%) | 45 ± (12) |
GOLD stages II, III, and IV (n, (%)) | 925 (44 %), 894 (42 %), 292 (14 %) |
BMI (kg/m2) | 26.6 ± (5.7) |
6MWD (m) | 370.1 ± (121.7) |
SGRQ (Total score) | 49.9 ± (20.1) |
mMRC dyspnoea (Median (IQR)) | 2 (1 – 2) |
CES-D score (Median (IQR)) | 9 (4 – 16) |